IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells - PubMed (original) (raw)

. 2009 Apr;39(4):1066-77.

doi: 10.1002/eji.200838773.

Affiliations

• PMID: 19266486
• DOI: 10.1002/eji.200838773

Free article

IL-10 interferes directly with TCR-induced IFN-gamma but not IL-17 production in memory T cells

Sandra Naundorf et al. Eur J Immunol. 2009 Apr.

Free article

Erratum in

• Eur J Immunol. 2009 May;39(5):1435

Abstract

IL-10 is a potent immunoregulatory and anti-inflammatory cytokine. However, therapeutic trials in chronic inflammation have been largely disappointing. It is well established that IL-10 can inhibit Th1 and Th2 cytokine production via indirect effects on APC. Less data are available about the influence of IL-10 on IL-17 production, a cytokine which has been recently linked to chronic inflammation. Furthermore, there are only few reports about a direct effect of IL-10 on T cells. We demonstrate here that IL-10 can directly interfere with TCR-induced IFN-gamma production in freshly isolated memory T cells in the absence of APC. This effect was independent of the previously described effects of IL-10 on T cells, namely inhibition of IL-2 production and inhibition of CD28 signaling. In contrast, IL-10 did not affect anti-CD3/anti-CD28-induced IL-17 production from memory T cells even in the presence of APC. This might have implications for the interpretation of therapeutic trials in patients with chronic inflammation where Th17 cells contribute to pathogenesis.

PubMed Disclaimer

Similar articles

• Prostaglandin E2 enhances Th17 responses via modulation of IL-17 and IFN-gamma production by memory CD4+ T cells.
  Napolitani G, Acosta-Rodriguez EV, Lanzavecchia A, Sallusto F. Napolitani G, et al. Eur J Immunol. 2009 May;39(5):1301-12. doi: 10.1002/eji.200838969. Eur J Immunol. 2009. PMID: 19384872
• Central role for TCR/CD3 ligation in the differentiation of CD4+ T cells toward A Th1 or Th2 functional phenotype.
  Röcken M, Müller KM, Saurat JH, Müller I, Louis JA, Cerottini JC, Hauser C. Röcken M, et al. J Immunol. 1992 Jan 1;148(1):47-54. J Immunol. 1992. PMID: 1345789
• Exogenous immunoglobulin downregulates T-cell receptor signaling and cytokine production.
  Tawfik DS, Cowan KR, Walsh AM, Hamilton WS, Goldman FD. Tawfik DS, et al. Pediatr Allergy Immunol. 2012 Feb;23(1):88-95. doi: 10.1111/j.1399-3038.2010.01129.x. Epub 2011 Jan 25. Pediatr Allergy Immunol. 2012. PMID: 21265884
• The two faces of interleukin 12: a pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells.
  Trinchieri G. Trinchieri G. Ciba Found Symp. 1995;195:203-14; discussion 214-20. doi: 10.1002/9780470514849.ch14. Ciba Found Symp. 1995. PMID: 8724839 Review.

Cited by

• Endotoxin-induced lung injury in α-galactosylceramide-sensitized mice is caused by failure of interleukin-4 production in lung natural killer T cells.
  Dagvadorj J, Tumurkhuu G, Naiki Y, Noman AS, Iftakhar-E-Khuda I, Badamtseren B, Komatsu T, Koide N, Yoshida T, Yokochi T. Dagvadorj J, et al. Clin Exp Immunol. 2010 Oct;162(1):169-77. doi: 10.1111/j.1365-2249.2010.04225.x. Epub 2010 Aug 19. Clin Exp Immunol. 2010. PMID: 20659123 Free PMC article.
• Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner.
  Huber S, Gagliani N, Esplugues E, O'Connor W Jr, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, Roncarolo MG, Battaglia M, Flavell RA. Huber S, et al. Immunity. 2011 Apr 22;34(4):554-65. doi: 10.1016/j.immuni.2011.01.020. Immunity. 2011. PMID: 21511184 Free PMC article.
• The CXCR4-STAT3-IL-10 Pathway Controls the Immunoregulatory Function of Chronic Lymphocytic Leukemia and Is Modulated by Lenalidomide.
  Shaim H, Estrov Z, Harris D, Hernandez Sanabria M, Liu Z, Ruvolo P, Thompson PA, Ferrajoli A, Daher M, Burger J, Muftuoglu M, Imahashi N, Li L, Liu E, Alsuliman AS, Basar R, Nassif Kerbauy L, Sobieski C, Gokdemir E, Kondo K, Wierda W, Keating M, Shpall EJ, Rezvani K. Shaim H, et al. Front Immunol. 2018 Jan 15;8:1773. doi: 10.3389/fimmu.2017.01773. eCollection 2017. Front Immunol. 2018. PMID: 29379494 Free PMC article.
• Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis.
  Rudick RA, Rani MR, Xu Y, Lee JC, Na J, Shrock J, Josyula A, Fisher E, Ransohoff RM. Rudick RA, et al. PLoS One. 2011;6(5):e19262. doi: 10.1371/journal.pone.0019262. Epub 2011 May 13. PLoS One. 2011. PMID: 21602934 Free PMC article. Clinical Trial.
• IKZF3/Aiolos Is Associated with but Not Sufficient for the Expression of IL-10 by CD4+ T Cells.
  Ridley ML, Fleskens V, Roberts CA, Lalnunhlimi S, Alnesf A, O'Byrne AM, Steel KJA, Povoleri GAM, Sumner J, Lavender P, Taams LS. Ridley ML, et al. J Immunol. 2020 Jun 1;204(11):2940-2948. doi: 10.4049/jimmunol.1901283. Epub 2020 Apr 22. J Immunol. 2020. PMID: 32321757 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Wiley

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal